Genetically engineered mice and their use in aging research

被引:4
作者
Andersen, JK [1 ]
机构
[1] Buck Inst Age Res, Novato, CA 94945 USA
关键词
transgenic; knockout; aging; age-related disease;
D O I
10.1385/MB:19:1:045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Genetically engineered animal models have been and will continue to be invaluable for exploring the basic mechanisms involved in the aging process as well as in extending our understanding of diseases found to be more prevalent in the older human population. Continued development of such in vivo systems will allow scientists to further dissect the role genetic and environmental factors play in aging and in age-related disease states and to enhance our understanding of these processes. In this article we discuss techniques involved in the development of such models and review some examples of laboratory mouse strains that have been used to study either normal aging or select diseases associated with aging.
引用
收藏
页码:45 / 57
页数:13
相关论文
共 110 条
  • [1] ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803
  • [2] Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system
    Abeliovich, A
    Schmitz, Y
    Fariñas, I
    Choi-Lundberg, D
    Ho, WH
    Castillo, PE
    Shinsky, N
    Verdugo, JMG
    Armanini, M
    Ryan, A
    Hynes, M
    Phillips, H
    Sulzer, D
    Rosenthal, A
    [J]. NEURON, 2000, 25 (01) : 239 - 252
  • [3] Sustained mammary gland-directed, ponasterone A-inducible expression in transgenic mice
    Albanese, C
    Reutens, AT
    Bouzahzah, B
    Fu, MF
    D'Amico, M
    Link, T
    Nicholson, R
    Depinho, RA
    Pestell, RG
    [J]. FASEB JOURNAL, 2000, 14 (07) : 877 - 884
  • [4] What causes the build-up of ubiquitin-containing inclusions in Parkinson's disease?
    Andersen, JK
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 2000, 118 (1-2) : 15 - 22
  • [5] Thymic atrophy in the mouse is a soluble problem of the thymic environment
    Aspinall, R
    Andrew, D
    [J]. VACCINE, 2000, 18 (16) : 1629 - 1637
  • [6] Immunosenescence: potential causes and strategies for reversal
    Aspinall, R
    Andrew, D
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2000, 28 : 250 - 254
  • [7] Baum L, 2000, MICROSC RES TECHNIQ, V50, P278, DOI 10.1002/1097-0029(20000815)50:4<278::AID-JEMT5>3.0.CO
  • [8] 2-T
  • [9] MACROPHAGE-SPECIFIC EXPRESSION OF HUMAN APOLIPOPROTEIN-E REDUCES ATHEROSCLEROSIS IN HYPERCHOLESTEROLEMIC APOLIPOPROTEIN E-NULL MICE
    BELLOSTA, S
    MAHLEY, RW
    SANAN, DA
    MURATA, J
    NEWLAND, DL
    TAYLOR, JM
    PITAS, RE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) : 2170 - 2179
  • [10] Bocan TMA, 1998, CURR PHARM DESIGN, V4, P37